Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...
Pulmonary function testing serves 2 important clinical goals: (1) categorizing the physiologic impairment from lung disease (ie, obstructive, restrictive, etc) and (2) quantifying the degree of ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. This is something I'm particularly ...
Good breathing is at the heart of good health. When asthma or shortness of breath appears, a person might be sent for pulmonary function tests. Arlene Dunlap of Piscataway, N.J. knows those tests well ...
Credit: Getty Images The road to race-neutral pulmonary function testing has been long and evolving; now, ATS recommends this approach and a Boston hospital offers an implementation model. In July, ...
Austin, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Pulmonary Function Testing Market Size & Growth Analysis: According to SNS Insider, the Pulmonary Function Testing Market size was valued at USD 3.39 ...
Maya Guglin 1, Shabnam Mehra 2, Thomas J. Mason 2, Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis, Pulmonary Circulation, Vol. 3, No. 2 (April 2013), pp. 406-413 ...
The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...
A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a ...
A woman presents with exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 ...
Campbellford Memorial Hospital has resumed pulmonary function testing, reducing travel for patients in Northumberland, ...
Insmed (NasdaqGS:INSM) plans to present new clinical and preclinical research on treprostinil palmitil inhalation powder (TPIP) at PVRI 2026. The company will share Phase 3 trial design and Phase 2b ...